
Results
3
Artificial intelligence (AI) is set to transform healthcare by enhancing diagnostics, personalizing medicine, boosting operational efficiency, expanding remote care, and accelerating research. AI outperforms humans in detecting diseases like cancer from scans, tailors treatments using genetic and lifestyle data, and streamlines hospital workflows with tools like predictive analytics and automated transcription. It powers telemedicine, monitors chronic conditions in real-time, and speeds up drug discovery by analyzing vast datasets for insights into complex diseases. Despite challenges like data privacy, bias, and integration costs, AI’s ability to improve accuracy, access, and affordability could save billions and extend lives, marking a seismic shift in healthcare delivery and outcomes.
3 companies
Guerbet
Market Cap: €132.5m
Provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide.
GBT
€10.50
7D
9.5%
1Y
-48.4%
Sanofi
Market Cap: €91.6b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SAN
€76.32
7D
1.5%
1Y
-17.8%
Median Technologies
Market Cap: €215.1m
Engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in France, the United States, Canada, the United Kingdom, China, and internationally.
ALMDT
€5.64
7D
2.5%
1Y
149.6%